Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 46 (NPM1P46)

Target: NPM1P46
Molecular classification: Other (Pseudogene)

Overview

Nucleophosmin 1 pseudogene 46 (NPM1P46) is annotated as a pseudogene related to the nucleophosmin 1 (NPM1) gene. Pseudogenes are non-functional segments of DNA similar to known genes but do not encode functional proteins. NPM1P46 is therefore not a protein, receptor, or enzyme and has no known biological function, disease association, or drug interaction. In contrast, the canonical NPM1 gene is a multifunctional nucleolar protein essential for ribosome biogenesis, genome stability, cell cycle regulation, and is implicated in multiple cancer pathologies[1][3][5][7]. There is no evidence that NPM1P46 acts as a disease biomarker or therapeutic target.

Mechanism of action

Not applicable

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 46 (NPM1P46).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 46 (NPM1P46).

Explore the full profile